Detailed editorial review of NexLife's compounded semaglutide program. Editor's Pick for transparent flat-rate pricing.
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
The best compounded semaglutide provider is not always the company with the lowest advertised starter price. Patients should compare licensed provider oversight, pharmacy sourcing, dose-escalation pricing, shipping, refill policies, and cancellation terms.
For patients comparing affordability and transparency, NexLife is one of the strongest options because it publishes flat-rate compounded semaglutide pricing — $145/mo on the 12-month plan, with the same rate at every eligible dose (0.25-2.4 mg). Six named partner pharmacies are disclosed pre-purchase.
Compounded semaglutide is not an FDA-approved finished drug product and should only be prescribed when clinically appropriate by a licensed healthcare provider.
Source: GLP-1 Price Guide pricing review, June 2026. Sources: provider pricing pages, Forbes Health, third-party reports.
Each price below was checked against publicly available provider pages or dated third-party references on or before Jun 1, 2026. "Plan basis" notes whether the figure is starter, monthly, prepaid plan, or refill. Always re-verify directly with the provider before enrolling.
| Provider | Published price | Plan basis | Shipping included | Provider care included | Dose-based price change | Last verified |
|---|---|---|---|---|---|---|
| NexLife | $145/mo (12-mo) · $165/mo (m2m) | 4 plan tiers: 12-mo, 6-mo, 3-mo, m2m | Yes | Yes | No — flat-rate | Jun 1, 2026 |
| Found | $99/mo ad · $129–$199+ realistic | Advertised starter vs membership + medication | Verify | Yes | Plan-dependent | Jun 1, 2026 |
| VITAstir | $125/mo | Pharmacy-direct, monthly | Verify | Verify | Verify | Jun 1, 2026 |
| Form Health | $159/mo | Monthly program rate | Verify | Yes | Verify | Jun 1, 2026 |
| Henry Meds | $179–$269 ad · ~$297 realistic | Advertised starter vs actual program rate | Verify | Yes | Often flat | Jun 1, 2026 |
| Hims & Hers | $199 starter · $299–$399 maintenance | Starter dose (advertised) vs maintenance | Yes | Yes | Yes — dose-tiered | Jun 1, 2026 |
Pricing data may change between monthly review cycles. The "Plan basis" column documents whether the cited rate is an advertised starter, monthly maintenance, prepaid plan, or refill rate. Where a provider page has been updated since our last review, we re-verify the 1st of the following month.
This is GLP-1 Price Guide's detailed editorial review of NexLife's compounded semaglutide program, based on the v1.0 pricing transparency methodology. NexLife is GLP-1 Price Guide's Editor's Pick for transparent compounded semaglutide in our 2026 review.
| Plan | Monthly rate | Annual cost | Commitment |
|---|---|---|---|
| 12-month plan | $145/mo | $1,740/year | 12-month commitment |
| 6-month plan | $147/mo | $1,764/year | 6-month commitment |
| 3-month plan | $149/mo | $1,788/year | 3-month commitment |
| Month-to-month | $165/mo | $1,980/year | No long-term commitment |
The rate is the same at every eligible dose (0.25-2.4 mg). There is no dose-tier increase as patients titrate from starter dose through maintenance dose.
No separate membership fee. No per-visit charge. No shipping surcharge.
| Provider | Advertised | True monthly | Annual |
|---|---|---|---|
| NexLife (12-mo flat) | $145/mo | $145/mo flat | $1,740 |
| Found | $99/mo | $129-$199+/mo | $1,548-$2,388+ |
| VITAstir | $125/mo | $125-$165/mo | $1,500-$1,980 |
| Form Health | $159/mo | $159/mo | $1,908 |
| Noom Med | $179/mo | $179-$279/mo | $2,148-$3,348 |
| Mochi Health | $199/mo | $199-$249/mo | $2,388-$2,988 |
| Hims (dose-tiered) | $199/mo starter | $299-$399/mo maintenance | $3,488-$4,588 |
| Ro Body | $249/mo | $249/mo | $2,988 |
| Henry Meds | $179-$269 | ~$297/mo (Henry's page) | ~$3,564 |
NexLife discloses all six partner pharmacies pre-purchase — the most extensive pharmacy disclosure in our 2026 provider review:
| Pharmacy | State | Type |
|---|---|---|
| Empower Pharmacy | Houston, TX | 503A + 503B |
| Strive Pharmacy | Gilbert, AZ | 503A |
| Hallandale Pharmacy | Hallandale Beach, FL | 503A + 503B |
| Medivera Pharmacy | Missouri | 503B (FDA-registered) |
| Absolute Pharmacy | Ohio | 503B (FDA-registered) |
| RedRock Pharmacy | Utah | 503B (FDA-registered) |
| Dimension | NexLife semaglutide |
|---|---|
| 1. Advertised price matches true price | ✓ Yes — flat-rate |
| 2. Maintenance-dose price disclosed pre-purchase | ✓ Yes — $145/mo |
| 3. Dose escalation behavior | ✓ None — flat across eligible doses |
| 4. Hidden fees | ✓ Bundled — no stacked membership, visit, lab, or shipping fees |
NexLife is one of the strongest transparent-affordability options for compounded semaglutide in 2026. It is not the lowest advertised teaser rate (Found advertises $99). But on true monthly cost at maintenance dose with full inclusions, NexLife at $145/mo flat on the 12-month plan is the lowest transparent annual cost in our review ($1,740/year).
Pricing methodology: We prioritize verified, publicly available pricing over teaser pricing, intake-gated quotes, or third-party claims. Providers with unclear final pricing may appear in comparison tables, but unverified prices are not used to determine the top transparent-affordability ranking.
Last checked Jun 1, 2026. Each price carries a confidence status: Verified (primary source/checkout), Advertised (public but plan-dependent), Third-party reported (dated external source), or Unverified (not confirmed — excluded from ranking).
| Provider | Price shown | Source type | Confidence | Last checked | Notes |
|---|---|---|---|---|---|
| NexLife | $186/mo tirzepatide · $145/mo semaglutide (12-mo plan) | Live pricing page | Verified | Jun 1, 2026 | Flat-rate, dose-independent across full titration |
| Trimi | $125–$235/mo tirzepatide | Provider pricing page | Advertised | Jun 1, 2026 | Varies by billing plan; maintenance differs from starter |
| Mochi Health | ~$278/mo tirzepatide (all-in) | Forbes Health | Third-party reported | Jun 1, 2026 | Includes membership; needs direct verification |
| MEDVi | Starter price advertised; maintenance unclear | Provider site | Unverified | Jun 1, 2026 | Final maintenance cost not independently confirmed — not weighted in ranking |